README

Supplementary data for the paper titled "Insights into Circulatory and Immunometabolic Imbalance from Metabolic Profiling in Kawasaki Disease" include:

Excel S1: Metabolomic data for the control group (Con, n=30) and Kawasaki disease group (KD, n=51).

Excel S2: Metabolomic data for the group before IVIG treatment (AT, n=19) and the group after IVIG treatment (BT, n=19).

Excel S3: Metabolite profiling with corresponding HMDB and KEGG identifiers.